{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:59:25Z","timestamp":1790553565402,"version":"4.1.0"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Arthritis &amp; Rheumatology"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Ankylosing spondylitis (<jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>) is an inflammatory arthritis in which men have a higher risk of developing progressive axial disease than women. Transcriptomic studies have shown reduced expression of cytotoxic cell genes in the blood of <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> patients. <jats:styled-content style=\"fixed-case\">HLA<\/jats:styled-content>\u2013B27 contributes the greatest risk for <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>, suggesting a role for <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells. This study was undertaken to profile <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> patient cytotoxic cells with the hypothesis that an alteration in <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells might explain the aberrant cytotoxic profile observed in patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Whole blood was examined for <jats:italic>GZM<\/jats:italic> and <jats:italic>PRF1<\/jats:italic> gene expression by quantitative polymerase chain reaction. Serum and synovial fluid (<jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>) were examined for granzyme and perforin 1 expression by bead array, and blood and <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> mononuclear cells were examined for granzyme and perforin 1 expression by fluorescence\u2010activated cell sorting (<jats:styled-content style=\"fixed-case\">FACS<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic><jats:styled-content style=\"fixed-case\">GZM<\/jats:styled-content><\/jats:italic> and <jats:italic><jats:styled-content style=\"fixed-case\">PRF1<\/jats:styled-content><\/jats:italic> gene expression were both reduced in <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> patients compared to healthy controls, especially in men. Perforin 1, but not granzyme, protein levels were reduced in <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> patient serum. Granzymes were elevated in <jats:styled-content style=\"fixed-case\">AS SF<\/jats:styled-content>, but not in rheumatoid arthritis or osteoarthritis <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content>. <jats:styled-content style=\"fixed-case\">FACS<\/jats:styled-content> revealed a reduction in granzyme\u2010positive and perforin 1\u2013positive lymphocytes, but not an intrinsic defect in <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cell granzyme or perforin 1 production. <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cell frequency was reduced in the blood and increased in the <jats:styled-content style=\"fixed-case\">SF<\/jats:styled-content> of <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings indicate that <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> patients have an altered cytotoxic T cell profile. These data suggest that <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells with a cytotoxic phenotype are recruited to the joints, where they exhibit an activated phenotype. Thus, a central role for <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>8+ T cells in <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> may have been overlooked and deserves further study.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.41129","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T03:39:56Z","timestamp":1570678796000},"page":"428-434","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Altered Cytotoxicity Profile of <scp>CD<\/scp>8+ T Cells in Ankylosing Spondylitis"],"prefix":"10.1002","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-435X","authenticated-orcid":false,"given":"Eric","family":"Gracey","sequence":"first","affiliation":[{"name":"University of Toronto Krembil Research Institute Toronto Western Hospital, and University Health Network  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Yao","sequence":"additional","affiliation":[{"name":"University of Toronto Krembil Research Institute, and University Health Network  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoya","family":"Qaiyum","sequence":"additional","affiliation":[{"name":"Krembil Research Institute Toronto Western Hospital, and University Health Network  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Lim","sequence":"additional","affiliation":[{"name":"Krembil Research Institute Toronto Western Hospital, and University Health Network  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tang","sequence":"additional","affiliation":[{"name":"Krembil Research Institute Toronto Western Hospital, and University Health Network  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Inman","sequence":"additional","affiliation":[{"name":"University of Toronto Krembil Research Institute Toronto Western Hospital, and University Health Network  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.56"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2667"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3528"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2018.07.012"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39464"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"e_1_2_6_9_1","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett S","year":"1994","journal-title":"J Rheumatol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206119"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI9295"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91760-J"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208677"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar386"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40028"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215349"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4023"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1067"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081242"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00441"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2006.106"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2013.07.013"}],"container-title":["Arthritis &amp; Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41129","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/art.41129","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.41129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T20:12:43Z","timestamp":1759954363000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/art.41129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1002\/art.41129"],"URL":"https:\/\/doi.org\/10.1002\/art.41129","archive":["Portico"],"relation":{},"ISSN":["2326-5191","2326-5205"],"issn-type":[{"value":"2326-5191","type":"print"},{"value":"2326-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"2019-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}